What is it about?
This study combines machine learning algorithms and molecular modeling to evaluate and predict the antiviral potential of pyrimidin-4(3H)-one derivatives against the influenza A (H1N1) virus. By testing a focused library of synthesized compounds, we identified a promising lead molecule, 6-amino-2-(dimethylamino)pyrimidin-4(3H)-one, that effectively inhibits viral reproduction in cell cultures, likely by targeting the endonuclease domain of the viral polymerase complex.
Featured Image
Why is it important?
Traditional drug discovery for viral infections often relies on costly and time-consuming trial-and-error experimental screening. Our dual-approach model not only accurately identifies active antiviral candidates but also reliably filters out unpromising, low-activity compounds prior to synthesis. Demonstrating that combined computer-driven models (machine learning and molecular docking) can streamline the discovery of influenza PA endonuclease inhibitors provides a cost-effective roadmap for developing novel anti-flu therapeutics.
Perspectives
Developing effective computational tools to narrow down chemical candidates before stepping into the wet lab is a critical step forward in modern drug design. It was deeply satisfying to see our theoretical predictions validated by in vitro biological assays. We hope this integrated methodology encourages researchers to adopt predictive modeling early in medicinal chemistry campaigns, accelerating the development of next-generation antiviral drugs with higher efficiency and lower financial costs.
Dr Stanislav A. Grabovskii
Ufa Institute of Chemistry of the RAS
Read the Original
This page is a summary of: Assessment of Anti-Influenza Activity of Pyrimidin-4(3H)-one Derivatives Using Prediction Models, Scientia Pharmaceutica, July 2026, MDPI AG,
DOI: 10.3390/scipharm94030060.
You can read the full text:
Contributors
The following have contributed to this page
